Enlivex Therapeutics to Buy Up to $1M in Bitcoin
Ticker: ENLV · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1596812
Sentiment: neutral
Topics: treasury-management, digital-assets, corporate-action
TL;DR
Enlivex is buying up to $1M in Bitcoin, diversifying treasury with crypto.
AI Summary
On November 20, 2024, Enlivex Therapeutics Ltd. announced that its board of directors approved the purchase of up to $1 million in Bitcoin. This strategic move is part of the company's treasury management strategy.
Why It Matters
This decision indicates a potential shift in how biotech companies manage their cash reserves, exploring digital assets as an investment.
Risk Assessment
Risk Level: medium — Investing in Bitcoin carries significant volatility and regulatory uncertainty, posing a risk to treasury value.
Key Numbers
- $1.0M — Bitcoin Purchase Authorization (Maximum amount approved by the board for Bitcoin acquisition.)
Key Players & Entities
- Enlivex Therapeutics Ltd. (company) — The company making the announcement and the Bitcoin purchase.
- Bitcoin (company) — The digital asset Enlivex Therapeutics Ltd. plans to purchase.
- $1 million (dollar_amount) — The maximum amount Enlivex Therapeutics Ltd. will spend on Bitcoin.
- November 20, 2024 (date) — The date of the announcement and board approval.
FAQ
What is the primary purpose of Enlivex Therapeutics Ltd.'s Bitcoin purchase?
The purchase is part of Enlivex Therapeutics Ltd.'s treasury management strategy.
When was the decision to purchase Bitcoin approved?
The board of directors approved the purchase on November 20, 2024.
What is the maximum amount Enlivex Therapeutics Ltd. plans to invest in Bitcoin?
Enlivex Therapeutics Ltd. has approved the purchase of up to $1 million of Bitcoin.
Under which jurisdiction is Enlivex Therapeutics Ltd. organized?
Enlivex Therapeutics Ltd. is organized under the laws of the State of Israel.
What is the ticker symbol for Enlivex Therapeutics Ltd.?
The filing does not explicitly state the ticker symbol, but the SEC file number is 001-36578.
Filing Stats: 218 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-11-20 08:02:27
Key Financial Figures
- $1 million — irectors approved the purchase of up to $1 million of Bitcoin as part of its cash manageme
Filing Documents
- ea022170301-6k_enlivex.htm (6-K) — 9KB
- ea022170301ex99-1_enlivex.htm (EX-99.1) — 7KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-100364.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Enlivex Therapeutics Ltd. (Registrant) By: /s/ Oren Hershkovitz Name: Title: Oren Hershkovitz Chief Executive Officer Date: November 20, 2024